BRPI0512921A - processo para tratamento e profilaxia de ms - Google Patents

processo para tratamento e profilaxia de ms

Info

Publication number
BRPI0512921A
BRPI0512921A BRPI0512921-4A BRPI0512921A BRPI0512921A BR PI0512921 A BRPI0512921 A BR PI0512921A BR PI0512921 A BRPI0512921 A BR PI0512921A BR PI0512921 A BRPI0512921 A BR PI0512921A
Authority
BR
Brazil
Prior art keywords
prophylaxis
treatment
multiple sclerosis
processes
new
Prior art date
Application number
BRPI0512921-4A
Other languages
English (en)
Inventor
Per Moestrup Jensen
Original Assignee
Den Kgl Veterinaer Og Landboho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Den Kgl Veterinaer Og Landboho filed Critical Den Kgl Veterinaer Og Landboho
Publication of BRPI0512921A publication Critical patent/BRPI0512921A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0225Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0008Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/58Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCESSO PARA TRATAMENTO E PROFILAXIA DE MS. A presente invenção fornece novas terapias e novos processos profiláticos para esclerose múltipla. São também fornecidos novos processos para diagnóstico. A invenção baseia-se na descoberta de que a esclerose múltipla é mais provavelmente causada pela infecção crónica com um microorganismo que possui reação cruzada imunologicamente com a espiroqueta Leptospira interrogans, que normalmente infecta o rato marrom.
BRPI0512921-4A 2004-07-01 2005-06-29 processo para tratamento e profilaxia de ms BRPI0512921A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200401042 2004-07-01
PCT/DK2005/000444 WO2006002631A1 (en) 2004-07-01 2005-06-29 Method for multiple sclerosis treatment and prophylaxis by treatment of leptospira infection

Publications (1)

Publication Number Publication Date
BRPI0512921A true BRPI0512921A (pt) 2008-04-22

Family

ID=34956480

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512921-4A BRPI0512921A (pt) 2004-07-01 2005-06-29 processo para tratamento e profilaxia de ms

Country Status (12)

Country Link
US (1) US20080193440A1 (pt)
EP (1) EP1778280A1 (pt)
JP (1) JP2008505130A (pt)
KR (1) KR20070046096A (pt)
CN (1) CN101010098A (pt)
AU (1) AU2005259726A1 (pt)
BR (1) BRPI0512921A (pt)
CA (1) CA2579779A1 (pt)
EA (1) EA200700263A1 (pt)
IL (1) IL180367A0 (pt)
NO (1) NO20070577L (pt)
WO (1) WO2006002631A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1920782A1 (en) * 2006-11-10 2008-05-14 Glycotope Gmbh Carboyhdrate specific cellular immunity inducing microorganisms and fractions thereof
AU2009315230A1 (en) * 2008-11-12 2010-05-20 The Brigham And Women's Hospital, Inc. Diagnosis of multiple sclerosis
NZ577731A (en) * 2009-06-16 2010-08-27 Innate Therapeutics Ltd Compositions and methods for treatment of multiple sclerosis
CN101874898A (zh) * 2010-06-21 2010-11-03 严杰 预防不同血清群问号钩端螺旋体感染的通用型三价基因重组疫苗及其制备方法
WO2017058923A1 (en) 2015-09-28 2017-04-06 East Carolina University Aluminum based adjuvants for tolerogenic vaccination
CN117979992A (zh) * 2021-08-06 2024-05-03 耶鲁大学 钩端螺旋体毒力调节蛋白及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643754A (en) * 1994-05-25 1997-07-01 The Regents Of The University Of California Nucleic acids encoding a leptospira outer membrane protein
US6140083A (en) * 1998-07-23 2000-10-31 The Regents Of The University Of California Leptospiral outer membrane protein, LipL46
EP1565080B1 (en) * 2002-10-10 2014-01-15 Cornell Research Foundation, Inc. Novel immunogenic proteins of leptospira

Also Published As

Publication number Publication date
JP2008505130A (ja) 2008-02-21
WO2006002631A1 (en) 2006-01-12
CN101010098A (zh) 2007-08-01
EP1778280A1 (en) 2007-05-02
IL180367A0 (en) 2007-06-03
NO20070577L (no) 2007-03-30
AU2005259726A1 (en) 2006-01-12
CA2579779A1 (en) 2006-01-12
US20080193440A1 (en) 2008-08-14
KR20070046096A (ko) 2007-05-02
EA200700263A1 (ru) 2007-06-29

Similar Documents

Publication Publication Date Title
BRPI0512921A (pt) processo para tratamento e profilaxia de ms
BRPI0720569B8 (pt) compostos de tetraciclina substituída e uso dos ditos compostos para o tratamento de uma infecção bacteriana, viral ou parasitária
BR112014004444A2 (pt) composições e métodos que compreendem uma variante de enzima lipolítica
BR112013027171A2 (pt) trocador de calor e método para sua produção
BR112013032711A2 (pt) composições farmacêuticas compreendendo sulbactam e inibidor de beta-lactamase
MX2009009207A (es) Metodos y composiciones para normalizar las secreciones de glandulas meibomianas.
BRPI0503785A (pt) sistema eletrÈnico de permuta de dados
MX2009001342A (es) Composiciones y metodos para el tratamiento de proctosigmoiditis por radiacion.
BRPI0612309B8 (pt) compostos e composições farmacêuticas antivirais
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
MA29369B1 (fr) Dosage fixe d'anticorps anti-her
MX337081B (es) Anticuerpo anti-nr10 y su uso.
BRPI0509903A (pt) uso de compostos peptìdicos para profilaxia e tratamento da cefaléia crÈnica
BR112015007616A2 (pt) inibidores de mek no tratamento de doenças por vírus
NO20060242L (no) Kombinasjonen av en serotonin-reopptaksinhibitor og agomelatin
BRPI0518290A2 (pt) processo para a fabricaÇço de um composto alquenil aromÁtico sob baixas condiÇÕes de processo de vapor-para-àleo
NO20035571L (no) N-formyl hydroksylaminforbindelser som PDF-inhibitorer
BRPI0414177A (pt) inibidores de girase
BR112012019561A2 (pt) hetarilamino naftiridinas
CL2021003244A1 (es) Tratamientos de angioedema hereditario
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
BR112018013187A2 (pt) método e aparelho para inibir a interrupção de conteúdo sendo consumido por um usuário
BR0112497A (pt) Antìgenos de streptococcus pyogenes
NO20051168L (no) Anvendelse av fermentert hvetekimekstrakt som anti-inflammasjonsmiddel
TR201820975A2 (tr) İbuprofen, Psödoefedrin ve Erdostein İçeren Uzatılmış Salım Sağlayan Farmasötik Kompozisyon

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]